Oxford Nanopore at ACMG 2026
)
Oxford Nanopore will be at the ACMG Annual Meeting in March, 2026, hosted in Baltimore. We will also host an Industry Supported Satellite Symposium on Tuesday, March 10. See additional details below.
Industry Supported Satellite Symposium
Unrestricted Disease Insights with Comprehensive Long-read Sequencing
Date: Tuesday, March 10
Time: 4:00 PM – 5:30 PM EST
Location: Hilton Baltimore Inner Harbor, Holiday rooms 1-3
Although exome and short-read whole genome sequencing are widely used clinically, diagnostic yield remains incomplete. This is well-recognised in rare disease but equally relevant to complex conditions. Learn how simultaneous detection of clinically signifi cant variants— complex structural variants, repeat expansions, copy number variants, methylation changes—can substantially improve diagnostic yield.
Learning Objectives:
Unaltered DNA sequencing strategy: including comprehensive variant calling and methylation in unresolved rare disease samples
Ultra-rapid whole genome sequencing, from sample to prioritized variants in 24h
Profile genome-wide methylation and variants in complex disease
Agenda
4:00-5:30 PM ET | Talk title | Speaker |
|---|---|---|
4:00 - 4:15 PM | Welcome and introductions | Cora Vacher, Oxford Nanopore Technologies |
4:15 - 4:40 PM | Talk title TBC | Tjakko van Ham, Erasmus University Rotterdam |
4:40 -5:05 PM | Native methylation sequencing for detection and monitoring of Alzheimer’s, Parkinson’s, ALS, and other neurodegenerative conditions | Chad Pollard, Wasatch Biolabs |
5:05 - 5:30 PM | Diagnosing the undiagnosed with long read genome data | Wendy Chung, Boston Children's Hospital |
